Shuttle Pharmaceuticals, UCFS Strike Sponsored Research Agreement

Posted on by admin

Collaboration aims to enhance PSMA-B ligand, a novel theranostic molecule in development for the treatment of prostate cancer.

Leave a Reply

Your email address will not be published. Required fields are marked *